HZNP Overview
Upcoming Projects (HZNP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (HZNP)
-
A Third Opinion: Discussing the FDA warning label for Horizon's Tepezza for TED and how severe hearing-related side effects may alter prescribing patterns
Ticker: HZNP
Executed On: Sep 15, 2023 at 12:30 PM EDT -
A Second Opinion: Discussing the FDA warning label for Horizon's Tepezza for TED and how severe hearing-related side effects may alter prescribing patterns
Ticker: HZNP
Executed On: Aug 25, 2023 at 10:00 AM EDT -
Discussing the FDA warning label for Horizon's Tepezza for TED and how severe hearing-related side effects may alter prescribing patterns
Ticker: HZNP
Executed On: Aug 09, 2023 at 03:05 PM EDT -
A third look: Discussing the potential of TEPEZZA (teprotumumab-trbw) in chronic thyroid eye disease(TED) and it's current role in TED treatment landscape.
Tickers: AMGN, HZNP
Executed On: Apr 19, 2023 at 06:00 PM EDT -
A second look: Discussing the potential of TEPEZZA (teprotumumab-trbw) in chronic thyroid eye disease(TED) and it's current role in TED treatment landscape.
Tickers: AMGN, HZNP
Executed On: Apr 17, 2023 at 08:00 AM EDT -
Discussing the potential of TEPEZZA (teprotumumab-trbw) in chronic thyroid eye disease(TED) and it's current role in TED treatment landscape.
Tickers: AMGN, HZNP
Executed On: Apr 14, 2023 at 11:00 AM EDT -
Discussing the standard of care for chronic gout and potential of SEL-212 from Selecta Biosciences
Tickers: SELB, HZNP
Executed On: Mar 21, 2023 at 05:15 PM EDT -
A second look at the Phase 2 data of Horizon's dazodalibep for Sjögren’s Syndrome
Tickers: HZNP, AMGN
Executed On: Feb 14, 2023 at 11:00 AM EST -
A look at the Phase 2 data of Horizon's dazodalibep for Sjögren’s Syndrome
Tickers: AMGN, HZNP
Executed On: Feb 07, 2023 at 01:00 PM EST -
A third look at the treatment landscape of chronic gout and the impact of the MIRROR-RCT trial for patients with gout and Chronic kidney disease
Ticker: HZNP
Executed On: Jan 05, 2023 at 04:00 PM EST -
A second look at the treatment landscape of chronic gout and the impact of the MIRROR-RCT trial for patients with gout and Chronic kidney disease
Ticker: HZNP
Executed On: Jan 04, 2023 at 04:00 PM EST -
A look at the treatment landscape of chronic gout and the impact of the MIRROR-RCT trial for patients with gout and Chronic kidney disease
Ticker: HZNP
Executed On: Dec 21, 2022 at 01:00 PM EST -
Å second look Evaluating the Market Potential of Uplizna As A Treatment For Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ticker: HZNP
Executed On: Jul 22, 2022 at 02:00 PM EDT -
Evaluating the Market Potential of Uplizna As A Treatment For Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ticker: HZNP
Executed On: Jul 19, 2022 at 04:30 PM EDT -
A final look at the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout
Ticker: HZNP
Executed On: Jun 16, 2022 at 01:00 PM EDT -
A Third look at the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout
Ticker: HZNP
Executed On: Jun 16, 2022 at 11:00 AM EDT -
A Second look at the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout
Ticker: HZNP
Executed On: Jun 15, 2022 at 04:30 PM EDT -
Discussing the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout
Ticker: HZNP
Executed On: Jun 09, 2022 at 03:00 PM EDT -
A Second Opinion: Checking on the launch of Tepezza and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Ticker: HZNP
Executed On: Feb 02, 2022 at 06:00 PM EST -
Checking on the launch of Tepezza and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Ticker: HZNP
Executed On: Jan 25, 2022 at 05:00 PM EST
Upcoming & Overdue Catalysts (HZNP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (HZNP)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
